Filing Flows › Medtronic (MDT) › Q1 FY27 › vs Q4 FY26
Medtronic (MDT) Q1 FY27 vs Q4 FY26 (quarter over quarter)
Medtronic's revenue fell $51.0M (-0.5%) from $9.8B in Q4 FY26 to $9.8B in Q1 FY27. Operating margin 18.1% against 19.1% (-1.0 pts).
Medtronic, Q1 FY27: revenue $9.8B (+14% year over year), operating margin 18.1%, net earnings $1.5B, operating cash flow $1.8B. The chart draws each line against Q4 FY26, the increases inside each band.
Margins
| Q1 FY27 | Q4 FY26 | Change | |
|---|---|---|---|
| Operating margin | 18.1% | 19.1% | -1.0 pts |
| Net margin | 15.1% | 12.7% | +2.4 pts |
Every line
| Line | Q1 FY27 | Q4 FY26 | Change | % |
|---|---|---|---|---|
| Revenue | $9.8B | $9.8B | −$51.0M | -0.5% |
| Operating profit | $1.8B | $1.9B | −$109M | -6% |
| Costs & expenses | $8.0B | $7.9B | $58.0M | +0.7% |
| Pre-tax earnings | $1.8B | $1.8B | −$65.0M | -4% |
| Cost of revenue | $3.4B | $3.4B | $18.0M | +0.5% |
| Research & development | $771M | $671M | $100M | +15% |
| SG&A | $3.2B | $3.1B | $141M | +5% |
| Other operating costs | $607M | $808M | −$201M | -25% |
| Net earnings | $1.5B | $1.2B | $226M | +18% |
| Minority interests | $9.0M | $15.0M | −$6.0M | -40% |
| Income tax | $289M | $575M | −$286M | -50% |
| Depreciation & amortization | $729M | $716M | $13.0M | +2% |
| Share-based compensation | $125M | $95.0M | $30.0M | +32% |
| Working capital & other | $531M | −$518M | $1.0B | — |
| Operating cash flow | $1.8B | $2.6B | −$780M | -30% |
Questions
How much did Medtronic's revenue grow quarter over quarter in Q1 FY27?
Medtronic's revenue fell $51.0M (-0.5%) from $9.8B in Q4 FY26 to $9.8B in Q1 FY27. Operating margin 18.1% against 19.1% (-1.0 pts).